Top 5 Infectious Disease News Stories Week of May 18 to May 24
Ceftobiprole Launches Commercially in US Innoviva Specialty Therapeutics, which is a subsidiary of Innoviva, announced its antibiotic, ceftobiprole (Zevtera), is available for prescribing in the US. The antibiotic was approved in April 2024, and now marks the first cephalosporin indicated to treat SAB.1 “The availability of Zevtera in the US marks the introduction of our […]
